| pubmed-article:10631459 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0555952 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:10631459 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:10631459 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:10631459 | pubmed:dateCreated | 2000-2-10 | lld:pubmed |
| pubmed-article:10631459 | pubmed:abstractText | Metastases confined to the liver is a frequent situation in patients with advanced colorectal cancer. For non-operable patients, 5-FU-based chemotherapy is often proposed but the importance of the choice of first line 5-FU regimen remains debatable. | lld:pubmed |
| pubmed-article:10631459 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10631459 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10631459 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10631459 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10631459 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10631459 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10631459 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10631459 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:10631459 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:10631459 | pubmed:author | pubmed-author:BuyseMM | lld:pubmed |
| pubmed-article:10631459 | pubmed:author | pubmed-author:WolmarkNN | lld:pubmed |
| pubmed-article:10631459 | pubmed:author | pubmed-author:PiedboisPP | lld:pubmed |
| pubmed-article:10631459 | pubmed:author | pubmed-author:HaddadEE | lld:pubmed |
| pubmed-article:10631459 | pubmed:author | pubmed-author:ThirionPP | lld:pubmed |
| pubmed-article:10631459 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10631459 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10631459 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10631459 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10631459 | pubmed:pagination | 1317-20 | lld:pubmed |
| pubmed-article:10631459 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:meshHeading | pubmed-meshheading:10631459... | lld:pubmed |
| pubmed-article:10631459 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10631459 | pubmed:articleTitle | Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer. | lld:pubmed |
| pubmed-article:10631459 | pubmed:affiliation | Department of Oncology, Henri Mondor Hospital, Créteil, France. | lld:pubmed |
| pubmed-article:10631459 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10631459 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10631459 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10631459 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10631459 | lld:pubmed |
